If you click “Continue” below, you will leave the current site and be taken to a site maintained by a third party that is solely responsible for its content. Amgen provides this link as a service to website visitors. Amgen is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.*
The 2018 AHA/ACC/Multi-society guideline supports the use of tools and techniques to facilitate shared decision-making discussions between the provider and the patient.
These conversations may increase the patient’s understanding of their condition and associated risks. Consider using the materials below during the shared decision-making discussions with your patients.
Do your patients know their ASCVD journey by heart? Consider sharing this resource to inform your patients of what they can expect after an ASCVD event.
View this patient-friendly interactive artery showing how plaque builds up.
You can create a resource to educate your patients about the risk of high LDL-C.
Share the American Heart Association's infographic about how cholesterol levels affect the risk of myocardial infarction and stroke.
Share the American Heart Association’s guide to understanding and managing cholesterol, which patients can review on their own time.
Access resources from Family Doctor, created by family physicians for patients to learn how to help prevent, understand, and manage illnesses associated with elevated cholesterol.
Access resources from Family Heart that empower patients to learn more about Familial Hypercholesteremia (FH) and Lp(a).
Access resources from National Forum for shared decision-making conversation guides for healthcare professionals and patients.
These third-party resources are for your information only. Amgen does not endorse and is not responsible for the content included in these resources.
AHA/ACC = American Heart Association/American College of Cardiology; ASCVD = atherosclerotic cardiovascular disease ; Lp(a) = lipoprotein (a).
